Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 41

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 9:45 AM IST
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
    Trivitron Healthcare gets Ravish Mittal as new Group CFO

    Trivitron Healthcare gets Ravish Mittal as new Group CFO

    Medical Dialogues Bureau24 Dec 2019 9:32 AM IST
    'In his new role, Ravish Mittal will be at the helm of the company's finances, organisational growth and expansion plans,' Trivitron Healthcare...
    Allergan acute migraine drug Ubrelvy wins USFDA approval

    Allergan acute migraine drug Ubrelvy wins USFDA approval

    Medical Dialogues Bureau24 Dec 2019 9:30 AM IST
    Allergan Plc's drug, Ubrelvy, is the first oral version of a new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors to win the...
    Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations

    Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations

    Medical Dialogues Bureau24 Dec 2019 9:00 AM IST
    The vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
    Johnson and Johnson wins baby powder-cancer litigation case in US

    Johnson and Johnson wins baby powder-cancer litigation case in US

    Medical Dialogues Bureau23 Dec 2019 12:43 PM IST
    The litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson (JnJ), finding Johnson's baby powder...
    Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA

    Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA

    Medical Dialogues Bureau23 Dec 2019 10:00 AM IST
    "Glenmark will continue to fully cooperate with the FDA as the agency evaluates ranitidine products for the presence of NDMA (a substance that could...
    Lupin to provide access to latest developments in field of gastroenterology in India

    Lupin to provide access to latest developments in field of gastroenterology in India

    Medical Dialogues Bureau23 Dec 2019 9:45 AM IST
    Through this initiative, Lupin aims to bring in global educational material and provide access to the latest developments in the field of...
    GSK fails to secure USFDA nod for HIV injection Cabenuva

    GSK fails to secure USFDA nod for HIV injection Cabenuva

    Medical Dialogues Bureau23 Dec 2019 9:40 AM IST
    The unit of GSK, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new...
    IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney

    IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney

    Medical Dialogues Bureau23 Dec 2019 9:00 AM IST
    It has focused on breast tumours, but now the U.S. Food and Drug Administration (USFDA) approved new uses, such as against tumours in the kidney,...
    Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil

    Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil

    Medical Dialogues Bureau22 Dec 2019 10:01 AM IST
    "Today, the manufacturing cost of atovaquone is believed to pose a barrier to the widespread use of atovaquone-proguanil based products in...
    Lupin unveils generic equivalent of Hectorol Injection

    Lupin unveils generic equivalent of Hectorol Injection

    Medical Dialogues Bureau22 Dec 2019 9:40 AM IST
    Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials, is the therapeutic generic equivalent of Sanofi Genzyme’s Hectorol Injection, 4...
    Cadila Healthcare Gujarat facility clears USFDA inspection

    Cadila Healthcare Gujarat facility clears USFDA inspection

    Farhat Nasim22 Dec 2019 9:30 AM IST
    "We hereby inform that the USFDA inspected the Company’s topical manufacturing facility located in Ahmedabad from 16th to 20th December 2019," Cadila...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok